Skip to main content
For Healthcare Professionals

Reset all filters

101 - 102 of 102 results

Publications

Gathering our presentations, posters, abstracts, and publications, this educational resource offers materials across topics of interest in oncology. Explore the current topics below and revisit regularly to access the latest materials.

Infographic

First-in-human dose-escalation trial of BI 764532, a delta-like ligand 3/CD3 IgG-like T cell engager, in patients with DLL3-positive small-cell lung cancer and neuroendocrine carcinoma
First-in-human dose-escalation trial of BI 764532, a delta-like ligand 3/CD3 IgG-like T cell engager, in patients with DLL3-positive small-cell lung cancer and neuroendocrine carcinoma
Author(s): Wermke et al.
SCLC, NEC/epNEC, LCNEC-L DLL3/CD3 TcE Infographic
Download
beamion-lung-1-phase-1-zongertinib-bi-1810631-her2-tki-advanced-solid-tumors
Updated data from the Phase I Beamion™ LUNG-1 trial of the HER2 tyrosine kinase inhibitor, BI 1810631, as monotherapy in patients with advanced/metastatic solid tumors with HER2 aberrations
Author(s): Heymach et al.
Solid tumors, NSCLC HER2 TKI Infographic
Download